Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 124

Sort by

Sort Order Select

Journal Articles

Efficacy and Tolerance of Interferon-α in Hypereosinophilic Syndromes. a Retrospective Multicenter Study on 29 Patients

Pauline De Malglaive, MD, Matthieu Groh, MD, Guillaume Lefèvre, MD PhD, Chafika Morati Hafsaoui, MD, Magda Alexis, MD, Mathilde Hunault, MD PhD, Julien Seneschal, MD PhD, Hilaire Charlanne, MD, Claude Preudhomme, PharmD, PhD, Bernard Bonnotte, MD PhD, Jean Emmanuel Kahn, PhDMD

Blood (2019) 134 (Supplement_1): 2322.

https://doi.org/10.1182/blood-2019-131687

Published: 2019

Journal Articles

Immunophenotypic Patterns of Bone Marrow Eosinopoiesis in Patients with Hypereosinophillic Syndrome and Systemic Mastocytosis

Christopher Trindade, MD, Xiaoping Sun, PhD, Dragan Maric, PhD, Chunjie Jiang, Christopher S. Hourigan, DPhil FACP FRCP, Dean D. Metcalfe, MD, Amy Klion, MD, Irina Maric, MD MSci

Blood (2018) 132 (Supplement 1): 4294.

https://doi.org/10.1182/blood-2018-99-118797

Published: 2018

Journal Articles

Characterization of a Mouse Model of Hypereosinophilic Syndrome

Nives Zimmermann, MD, William J Gibbons, Jr., Shelli M Homan, Andrea Klingler, Daniel R Prows, PhD

Blood (2018) 132 (Supplement 1): 3686.

https://doi.org/10.1182/blood-2018-99-113909

Published: 2018

Journal Articles

All Itching Is Not Benign; A Case of Refractory Hypereosinophilic Syndrome Treated with Off Label CD52 Inhibitor-Alemtuzumab

Rehan Ansari, MD, Elva Nora Osuna Salazar, MD, Nabeel Sarhill, MD, Laura E Garcia, MD, James Hanley, MD

Blood (2018) 132 (Supplement 1): 5485.

https://doi.org/10.1182/blood-2018-99-118271

Published: 2018

Journal Articles

Panch SR, Bozik ME, Brown T, et al. Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes. Blood. 2018;132(5):501-509.

Blood (2018) 132 (13): 1461.

https://doi.org/10.1182/blood-2018-08-870204

Published: 2018

Journal Articles

Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes

Sandhya R. Panch, Michael E. Bozik, Thomas Brown, Michelle Makiya, Calman Prussin, Donald G. Archibald, Gregory T. Hebrank, Mary Sullivan, Xiaoping Sun, Lauren Wetzler, JeanAnne Ware, Michael P. Fay, Cynthia E. Dunbar, Steven I. Dworetzky, Paneez Khoury, Irina Maric, Amy D. Klion

Blood (2018) 132 (5): 501–509.

https://doi.org/10.1182/blood-2018-02-835330

Published: 2018

Includes: Supplemental data

Journal Articles

Aautoimmune Hemolytic Anemia: Pattern of Clinical Presentation and Management Outcome — a Nine Year Observation from a Tertiary Care Hospital in Saudi Arabia

Mahsen AlSaleh, MD, Tarek Owaidah, MD, Abdullah AlJefri, MD, Saba Parween, MBBS, Roula Barmada, MD, Silgy Jose, RN, Bouchra Safi, RN, Viqaruddin Mohammed, MSc, CCRP, Joumana AlEita, MD

Blood (2017) 130 (Supplement 1): 4744.

https://doi.org/10.1182/blood.V130.Suppl_1.4744.4744

Published: 2017

Journal Articles

A Novel JAK2 Mutation Confers Cytokine-Independence in the Absence of a Type I Dimeric Cytokine Receptor

Ami B. Patel, MD, Anca Franzini, PhD, Emilie Leroy, PhD, Dongqing Yan, Anna M. Eiring, PhD, Stefan N. Constantinescu, MD PhD, Thomas O'Hare, PhD, Michael W. Deininger, MD PhD

Blood (2017) 130 (Supplement 1): 4212.

https://doi.org/10.1182/blood.V130.Suppl_1.4212.4212

Published: 2017

Journal Articles

Dexpramipexole As a Steroid-Sparing Agent in Hypereosinophilic Syndromes (HES): An Open-Label Proof-of-Concept Study

Sandhya R. Panch, MD MPH, Michael Bozik, MD, Thomas Brown, RN, Ulrike Demarco, Dipl. Biol., Jamie Hahn, BS, Alexander Komarov, PhD, Tamika Magee, RN, Michelle Makiya, RN, Calman Prussin, MD, Armando Signore, PhD, Mary Sullivan, BA, Lauren Wetzler, MHS, PA, Cynthia E. Dunbar, MD, Steven Dworetzky, PhD, Irina Maric, MD, Amy D Klion, MD

Blood (2016) 128 (22): 1327.

https://doi.org/10.1182/blood.V128.22.1327.1327

Published: 2016

Journal Articles

Staring inside of Idiopathic Hypereosinophilia: Identification of Clonality Using Targeted Exome Sequencing

Jee-Soo Lee, Heewon Seo, Kyongok Im, Si Nae Park, Jung-Ah Kim, MD PhD, Seon Young Kim, MD PhD, Joon-hee Lee, Sunghoon Kwon, Insong Koh, Seungwoo Hwang, Heung-Woo Park, Hye-Ryun Kang, Ju Han Kim, MD PhD, Miyoung Kim, MD, Dong Soon Lee

Blood (2016) 128 (22): 3119.

https://doi.org/10.1182/blood.V128.22.3119.3119

Published: 2016

Journal Articles

Increased Prevalence of t(8;9)(p21-23;p23-24) Translocations within 9p24 Abnormalities in Patients with Myeloid Malignancies Identified from the Mitelman Database

Matthew K Stein, MD, Dilan Patel, MD, Andrew Hahn, MD, Jamie Riney, MD, Michael G. Martin, MD

Blood (2016) 128 (22): 1935.

https://doi.org/10.1182/blood.V128.22.1935.1935

Published: 2016

Journal Articles

Tumor Markers in Diagnosis and Follow up of Haematologic Malignancies

Zisis Kontoninas, MD PhD, Georgia D Kaiafa, MD PhD, Zoi Saouli, MD PhD Haematologist, Christos G Savopoulos, Associate Prof of Internal MDcine, Didangelos Triantafyllos, Assistant Prof of Internal MDcine, Achilles Anagnostopoulos, Apostolos I Hatzitolios, Professor of Internal MDcine, Athanasios Papadopoulos, Professor of Haematology

Blood (2016) 128 (22): 5337.

https://doi.org/10.1182/blood.V128.22.5337.5337

Published: 2016

Journal Articles

Ruxolitinib Used to Treat Hypereosinophilic Syndrome

Seung Lee, bs, Coby Palmares, Niko Koutsoukos, J. Brice Weinberg, MD, Trisa Palmares, MD, Alice Song, MD, Harold Song, MD, Sheila Benedicto, bs, Michael Song, bs, Vu Phan, MD, Julia Song, MD

Blood (2016) 128 (22): 5500.

https://doi.org/10.1182/blood.V128.22.5500.5500

Published: 2016

Journal Articles

Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms

Adile Begum Bahcecioglu, Sezgin Etgul, Tuncay Aslan, Muruvvet Seda Aydın, Umit Yavuz Malkan, Mufide Okay, Evren Ozdemir, MD, Rafiye Ciftciler, Hakan Goker, MD, Yahya Buyukasik, MD

Blood (2016) 128 (22): 5483.

https://doi.org/10.1182/blood.V128.22.5483.5483

Published: 2016

Journal Articles

Lymphocytic variant of hypereosinophilic syndrome mimicking peripheral T-cell lymphoma in a young woman

Rebecca L. King, Matthew T. Howard

Blood (2016) 127 (2): 268.

https://doi.org/10.1182/blood-2015-10-674945

Published: 2016

Journal Articles

Etiology of Hypereosinophilia and Hypereosinophilic Syndromes in a Tropical Setting

Neelam Varma, MBBS, MD, Sreejesh S., MD, Shano Naseem, MD, Man Updesh Singh Sachdeva, MD, Subhash Varma, MBBS, MD, Pankaj Malhotra, MD MBBS

Blood (2015) 126 (23): 4082.

https://doi.org/10.1182/blood.V126.23.4082.4082

Published: 2015

Journal Articles

How I treat hypereosinophilic syndromes

Amy D. Klion

Blood (2015) 126 (9): 1069–1077.

https://doi.org/10.1182/blood-2014-11-551614

Published: 2015

Includes: Supplemental data

Journal Articles

An Unusual Case of Hypereosinophilic Syndrome

Anwarul Islam, MD

Blood (2014) 124 (21): 4965.

https://doi.org/10.1182/blood.V124.21.4965.4965

Published: 2014

Journal Articles

Midostaurin (PKC412) Demonstrates a High Rate of Durable Responses in Patients with Advanced Systemic Mastocytosis: Results from the Fully Accrued Global Phase 2 CPKC412D2201 Trial

Jason Gotlib, MD MS, Hanneke C. Kluin-Nelemans, MD PhD, Tracy I. George, MD, Cem Akin, MD PhD, Karl Sotlar, MD, Olivier Hermine, MD PhD, Farrukh Awan, MD MS, Elizabeth O Hexner, MD, Michael Mauro, MD, David Sternberg, MD PhD, Matthieu Villeneuve, Fabienne Emery-Salbert, MSc, Eric Stanek, PharmD, Karin Hartmann, MD, Hans-Peter Horny, MD, Peter Valent, MD, Andreas Reiter, MD

Blood (2014) 124 (21): 636.

https://doi.org/10.1182/blood.V124.21.636.636

Published: 2014

Journal Articles

Therapy-Related Myeloid Neoplasms: Report Of The Italian Network On Secondary Leukemias

Blood (2013) 122 (21): 2659.

https://doi.org/10.1182/blood.V122.21.2659.2659

Published: 2013

NARROW

Efficacy and Tolerance of Interferon-α in Hypereosinophilic Syndromes. a Retrospective Multicenter Study on 29 Patients

Immunophenotypic Patterns of Bone Marrow Eosinopoiesis in Patients with Hypereosinophillic Syndrome and Systemic Mastocytosis

Characterization of a Mouse Model of Hypereosinophilic Syndrome

All Itching Is Not Benign; A Case of Refractory Hypereosinophilic Syndrome Treated with Off Label CD52 Inhibitor-Alemtuzumab

Panch SR, Bozik ME, Brown T, et al. Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes. Blood. 2018;132(5):501-509.

Dexpramipexole as an oral steroid-sparing agent in hypereosinophilic syndromes

Aautoimmune Hemolytic Anemia: Pattern of Clinical Presentation and Management Outcome — a Nine Year Observation from a Tertiary Care Hospital in Saudi Arabia

A Novel JAK2 Mutation Confers Cytokine-Independence in the Absence of a Type I Dimeric Cytokine Receptor

Dexpramipexole As a Steroid-Sparing Agent in Hypereosinophilic Syndromes (HES): An Open-Label Proof-of-Concept Study

Staring inside of Idiopathic Hypereosinophilia: Identification of Clonality Using Targeted Exome Sequencing

Increased Prevalence of t(8;9)(p21-23;p23-24) Translocations within 9p24 Abnormalities in Patients with Myeloid Malignancies Identified from the Mitelman Database

Tumor Markers in Diagnosis and Follow up of Haematologic Malignancies

Ruxolitinib Used to Treat Hypereosinophilic Syndrome

Experience with Pegylated Interferon α-2a in 30 Patients Diagnosed with Hematologic Neoplasms

Lymphocytic variant of hypereosinophilic syndrome mimicking peripheral T-cell lymphoma in a young woman

Etiology of Hypereosinophilia and Hypereosinophilic Syndromes in a Tropical Setting

How I treat hypereosinophilic syndromes

An Unusual Case of Hypereosinophilic Syndrome

Midostaurin (PKC412) Demonstrates a High Rate of Durable Responses in Patients with Advanced Systemic Mastocytosis: Results from the Fully Accrued Global Phase 2 CPKC412D2201 Trial

Therapy-Related Myeloid Neoplasms: Report Of The Italian Network On Secondary Leukemias

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only